Jie Han

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

National Federation of the Blind(Current)

Jie Han is an author at National Federation of the Blind specializing in long-acting glp-1 receptor agonists, type 2 diabetes pharmacotherapy, and placebo-controlled efficacy assessment.

Publications per year

2024–2025

Publications

Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial

Dalong Zhu, Weimin Wang, Guoyu Tong et al. · Nature Communications · 2024 · 27 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Linong Ji, Leili Gao, Haibo Xue et al. · The Lancet Diabetes & Endocrinology · 2025 · 22 citations

Medicine, Endocrinology, Pharmacology +10

1–2 of 2